Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans

Loading...
Thumbnail Image
Date
2013
Journal Title
Journal ISSN
Volume Title
Publisher
HIV/AIDS – Research and Palliative Care
Abstract
With access to antiretroviral therapy (ART) expanding in resource-limited settings, assessing factors related to clinical, immunological, and virological outcomes of ART is of great importance. Even though ART is loosely referred to as a lifelong treatment, clinical, immunological and virological outcome measures differ among patients on highly active ART (HAART), with differences reported within and across cohorts.1–6 Mortality is among the ART-outcome variables that have been studied extensively, and rates of up to 30% have been reported during the first year of treatment in some sub-Saharan settings
Description
Keywords
Baseline CD4 cells, HIV severity, Immunological recovery, ART outcome, ART
Citation
Nanzigu, S., Kiguba, R., Kabanda, J., Mukonzo, JK, Waako, P., Kityo, C., & Makumbi, F. (2013). Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. HIV / AIDS (Auckland, NZ) , 5 , 309. http://dx.doi.org/10.2147/HIV.S50614